276 related articles for article (PubMed ID: 29914817)
21. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
[TBL] [Abstract][Full Text] [Related]
22. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.
Elbarbary NS
Diabetes Metab Res Rev; 2016 Sep; 32(6):623-33. PubMed ID: 26789012
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.
Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
Diabetes Technol Ther; 2019 Jan; 21(1):28-34. PubMed ID: 30585769
[TBL] [Abstract][Full Text] [Related]
26. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
[TBL] [Abstract][Full Text] [Related]
27. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
[TBL] [Abstract][Full Text] [Related]
28. Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.
Battelino T; Nimri R; Dovc K; Phillip M; Bratina N
Diabetes Care; 2017 Jun; 40(6):764-770. PubMed ID: 28351897
[TBL] [Abstract][Full Text] [Related]
29. Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up.
Coronel-Restrepo N; Blanco VM; Palacio A; Ramírez-Rincón A; Arbeláez S; Duque V; Pino JJ; Carvajal J; Bedoya J; Cuesta DP; Botero JF
Endocrinol Diabetes Nutr (Engl Ed); 2021 Oct; 68(8):567-572. PubMed ID: 34872640
[TBL] [Abstract][Full Text] [Related]
30. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
[TBL] [Abstract][Full Text] [Related]
31. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.
Danne T; Kordonouri O; Holder M; Haberland H; Golembowski S; Remus K; Bläsig S; Wadien T; Zierow S; Hartmann R; Thomas A
Diabetes Technol Ther; 2011 Nov; 13(11):1129-34. PubMed ID: 21827318
[TBL] [Abstract][Full Text] [Related]
32. Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.
Lepore G; Scaranna C; Corsi A; Dodesini AR; Trevisan R
Diabetes Technol Ther; 2020 Apr; 22(4):321-325. PubMed ID: 31617752
[TBL] [Abstract][Full Text] [Related]
33. Effect of real-life insulin pump with predictive low-glucose management use for 3 months: Analysis of the patients treated in a Japanese center.
Tsunemi A; Sato J; Kurita M; Wakabayashi Y; Waseda N; Koshibu M; Shinohara M; Ozaki A; Nakamura H; Hirano N; Ikeda F; Satoh H; Watada H
J Diabetes Investig; 2020 Nov; 11(6):1564-1569. PubMed ID: 32374513
[TBL] [Abstract][Full Text] [Related]
34. Optimal predictive low glucose management settings during physical exercise in adolescents with type 1 diabetes.
Cherubini V; Gesuita R; Skrami E; Rabbone I; Bonfanti R; Arnaldi C; D'Annunzio G; Frongia A; Lombardo F; Piccinno E; Schiaffini R; Toni S; Tumini S; Tinti D; Cipriano P; Minuto N; Lenzi L; Ferrito L; Ventrici C; Ortolani F; Cohen O; Scaramuzza A
Pediatr Diabetes; 2019 Feb; 20(1):107-112. PubMed ID: 30378759
[TBL] [Abstract][Full Text] [Related]
35. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
[TBL] [Abstract][Full Text] [Related]
36. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
Alotaibi A; Al Khalifah R; McAssey K
Pediatr Diabetes; 2020 Nov; 21(7):1256-1267. PubMed ID: 32738022
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of Automated Insulin Management Features of the MiniMed
Zhong A; Choudhary P; McMahon C; Agrawal P; Welsh JB; Cordero TL; Kaufman FR
Diabetes Technol Ther; 2016 Oct; 18(10):657-663. PubMed ID: 27672710
[TBL] [Abstract][Full Text] [Related]
38. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV
Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562
[TBL] [Abstract][Full Text] [Related]
39. The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.
Brazg RL; Bailey TS; Garg S; Buckingham BA; Slover RH; Klonoff DC; Nguyen X; Shin J; Welsh JB; Lee SW
J Diabetes Sci Technol; 2011 Nov; 5(6):1466-71. PubMed ID: 22226267
[TBL] [Abstract][Full Text] [Related]
40. The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.
Beato-Víbora PI; Gil-Poch E; Galán-Bueno L; Lázaro-Martín L; Arroyo-Díez FJ
J Diabetes Sci Technol; 2018 Nov; 12(6):1241-1243. PubMed ID: 30058373
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
